In the first quarter of 2025, SnP closed the deal for Exacta Asia Investment III, a fund managed by Mizuho Asia Partners, into its equity investment in PT Safelock Medical, an Indonesian company engaged in medical devices, marking a key step forward for Indonesia’s healthcare sector.

This cross-border transaction reflects continued interest from international investors in Indonesia’s medical and healthcare innovation space. The transaction involved coordination across various advisors and addressed key regulatory, commercial, ESG and structural considerations.

Indonesia's healthcare sector has seen significant growth in recent years, driven by rising demand for better medical infrastructure, increased government support, and a shift toward technology-driven solutions. With the expanding national economy and a growing health industry, the market presents strong opportunities for both domestic and international stakeholders. Investments like this demonstrate the sector's potential to attract long-term capital and deliver impactful innovation in healthcare.